跳至主要内容
临床试验/CTRI/2021/08/035634
CTRI/2021/08/035634尚未招募不适用

A study on Sanjeevani Vati with special reference to Pharmaceutico-Analytical,In Vitro Anti Microbial effect on common Diarrhoeal pathogens and its clinical evaluation as empirical therapy in Infective Diarrhoea

Principal RGGPG Ayurvedic College and Hospital Paprola1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2021年8月16日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
20
试验地点
1
主要终点
Relief in symptoms in patients of Infective Diarrhoea.

研究概览

简要总结

I would like to publish my research trial after completion of the trial as soon as possible. Patient will be selected from campus /faculty OPD of RGGPG Ayurvedic and Paprola. Two groups of 20 patients (10 in each group) will be assessed on the basis of inclusion and exclusion criteria to know the effect of Sanjeevani Vati and Noeflox -TZ.

研究设计

研究类型
Interventional
分配方式
Other
盲法
Open Label

入排标准

年龄范围
16.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.)Patients willing to go through trial.
  • 2.)Patients of age group b/w 16-60 yrs of either sex.
  • 3.)Clinically diagnosed and confirmed patients of infective Diarrhoea.

排除标准

  • 1.)Patients below the age of 16yrs and above the age of 60 yrs.
  • 2.)Patients with severe dehydration or suffering from AIDS,Cancer,TB,IBD.

结局指标

主要结局

Relief in symptoms in patients of Infective Diarrhoea.

时间窗: Duration of the treatment:It will be given for 5 days. | Route of administration : Oral | Follow up: After 5 days.

次要结局

  • General feeling of well being(5 Days)

研究者

发起方
Principal RGGPG Ayurvedic College and Hospital Paprola
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验